Assisi Foundation   Report issue

Foundation Phase 1 Phase 2
Founded: Memphis TN United States (1994)

Organization Overview

First Clinical Trial
2004
NCT00145626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now